# A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation

> **NCT03382613** · — · TERMINATED · sponsor: **Janssen Scientific Affairs, LLC** · enrollment: 2000 (actual)

## Conditions studied

- Atrial Fibrillation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03382613
- **Lead sponsor:** Janssen Scientific Affairs, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2017-12-29
- **Primary completion:** 2019-12-03
- **Final completion:** 2019-12-03
- **Target enrollment:** 2000 (ACTUAL)
- **Why stopped:** Operating Company decided to stop study due to strategic realignment and budgetary reasons
- **Last updated:** 2019-12-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03382613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03382613, "A Study to Quantify Use of Anticoagulation to Improve Management of Atrial Fibrillation". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03382613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*